The Mayo Test: Impact On Personalized Medicine And Beyond
With a unanimous decision issued on March 20, 2012, in Mayo v. Prometheus Laboratories, the U.S. Supreme Court invalidated the process claims of Prometheus' two patents as not patent-eligible based on...To view the full article, register now.
Already a subscriber? Click here to view full article